Question · asked by 1 review

Desmopressin vs placebo: Major adverse events

Population
Not specified
Intervention
Desmopressin
Comparison
placebo
Outcome
Major adverse events

Desmopressin showed no clear difference in major adverse events compared with placebo (low certainty).

What each review found

Include earlier review versions
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%
FindingEffectStudiesGRADE certainty
Desmopressin vs placebo
Major adverse events
Desmopressin showed no clear difference in major adverse events compared with placebo (low certainty).
Desmopressin for treating nocturia in men (2017) · Cochrane Headline outcomes only
RR 3.05 [0.13, 73.39]1 study · 115 participantsLow
Desmopressin vs placebo
Major adverse events
It is very uncertain whether desmopressin changes major adverse events compared with placebo (very low certainty).
Desmopressin for treating nocturia in men (2017) · Cochrane Headline outcomes only
RR 0.97 [0.1, 9.03]2 studies · 536 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Desmopressin for treating nocturia in men
2017 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.